Urolithiasis Clinical Trial
Official title:
Metabolic Evaluation of Urolithiasis: Comparison of 24-hour Collecting Urine Prior and After Stone Removal - a Prospective Study
NCT number | NCT03846011 |
Other study ID # | 2019-003 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2019 |
Est. completion date | August 31, 2020 |
The metabolic evaluation is crucial for determining possible underlying diseases causing stone growth and to consider the lifestyle changes or medical prophylaxis needed to prevent or at least reduce stone recurrence. 24-hour urine collection is the main part of the metabolic evaluation. The time point is suggested between 3 weeks and 3 month after stone removal, but so far there are no studies comparing 24-hour urine prior and after stone removal. In this study, investigators would like to analyze parameters in the 24-hour urine prior and after complete stone removal to see whether metabolic status can be evaluated no matter stone free or not.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | August 31, 2020 |
Est. primary completion date | February 28, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients 18 years or older - Urolithiasis (Nephrolithiasis, Ureterolithiasis) Exclusion Criteria: - Patients under 18 years - Urinary tract infection (positive urine culture prior to surgery) - Incomplete 24h urine collection - Pregnancy - Residual stones after surgery |
Country | Name | City | State |
---|---|---|---|
China | Department of Urology, The First Affiliated Hospital of Guangzhou Medical University | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
The First Affiliated Hospital of Guangzhou Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Urine pH Change | pH values will be determined with a glass electrode in a calibrated pH meter | Change from baseline urine pH at 4 weeks after proven stone free status | |
Primary | 24-h Urine oxalate excretion change | Urine oxalate will be measured using ion exchange chromatography | Change from baseline 24-h urine oxalate excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine citrate excretion change | Urine citrate will be measured using ion exchange chromatography | Change from baseline 24-h urine citrate excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine calcium excretion change | Urine calcium will be measured by Unicel DxC 600 synchronic biochemical detecting system. | Change from baseline 24-h urine calcium excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine phosphate excretion change | Urine phosphate will be measured by Unicel DxC 600 synchronic biochemical detecting system. | Change from baseline 24-h urine phosphate excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine sodium excretion change | Urine sodium will be measured by Unicel DxC 600 synchronic biochemical detecting system. | Change from baseline 24-h urine sodium excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine potassium excretion change | Urine potassium will be measured by Unicel DxC 600 synchronic biochemical detecting system. | Change from baseline 24-h urine potassium excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine chloride excretion change | Urine chloride will be measured by Unicel DxC 600 synchronic biochemical detecting system. | Change from baseline 24-h urine chloride excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine creatinine excretion change | Urine creatinine will be measured by Unicel DxC 600 synchronic biochemical detecting system. | Change from baseline 24-h urine creatinine excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine uric acid excretion change | Urine uric acid will be measured using Beckman coulter AU680 automatic biochemistry analyzer. | Change from baseline 24-h urine uric acid excretion at 4 weeks after proven stone free status | |
Primary | 24-h Urine magnesium excretion change | Urine magnesium will be measured using Beckman coulter AU680 automatic biochemistry analyzer. | Change from baseline 24-h urine magnesium excretion at 4 weeks after proven stone free status |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04021381 -
Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi
|
Phase 3 | |
Completed |
NCT02266381 -
A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy
|
N/A | |
Terminated |
NCT01431378 -
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
|
N/A | |
Completed |
NCT01451931 -
Study of Tomography of Nephrolithiasis Evaluation
|
Phase 4 | |
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Completed |
NCT02895711 -
Radiation Dose of Pediatric Patients During Ureteroscopy
|
||
Completed |
NCT05340075 -
Staged Bilateral Percutaneous Nephrolithotomy
|
||
Recruiting |
NCT03919227 -
Measurement of Resistance During UAS Insertion Procedure in RIRS
|
N/A | |
Recruiting |
NCT03717285 -
Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS
|
N/A | |
Completed |
NCT05340088 -
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
|
||
Completed |
NCT05032287 -
Medical Expulsive Therapy Post-SWL For Renal Stones
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Not yet recruiting |
NCT04080973 -
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia
|
N/A | |
Terminated |
NCT01736358 -
The Use of Intranasal Ketoralac for Pain Management (Sprix)
|
Phase 4 | |
Completed |
NCT01792765 -
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
|
N/A | |
Completed |
NCT06211842 -
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Not yet recruiting |
NCT04606758 -
Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease
|
N/A |